Search clinical trials for: AZD0754
Total 2 results
-
AstraZenecaNot yet recruitingHepatocellular Carcinoma | Prostate CancerUnited States
-
AstraZenecaRecruitingMetastatic Prostate CancerUnited States, Australia
Sponsors and Collaborators
- Prestige Biopharma Limited
- Reina Sofia University Hospital
- North Karelia Hospital District
- Grand Challenges Canada
- Veeda Oncology
- Chengdu Nuoen Biotechnologies, Inc.
- Bjørgene Omsorgssenter, Haugesund
- Maria Lendorf
- Neuregenix
- BayCare Health System
- Centro di Procreazione Assistita Demetra
- Bruce County Paramedic Service
- Women and children's hospital of Jiaxing university
- AIDS Council of New South Wales
- ImproveCareNow (ICN)
- Mononuclear Therapeutics Ltd.
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Equipe MiMes
- InflaRx GmbH
- Nestor Soler Porcar, MD, PhD
- View Full List
Medical Conditions
- Multisystem Proteinopathy
- Pulmonary Adenocarcinoma
- Predictors of Atrial Fibrillation Recurrences
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Fetus or Neonate Affected by External Version Before Labor
- Endocarditis Infective
- Skull Base Neoplasms
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Fracture Dislocation of Cervical Spine
- Spine Surgeries
- Painless Hysteroscopy
- Chlamydophila Infections
- Childhood Langerhans Cell Histiocytosis
- Gullian Barre Syndrome
- Ewing's Family Tumors
- Closure; Foramen Ovale
- Epidemic Hemorrhagic Fever
- Tay-Sachs Disease Ganglioside
- Psoriasis, Arthritic
- View Full List
Drug Interventions
- Azelastine hydrochloride (BAYR9258)
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Qingkailing injection 40 ml
- Estradiol+Drospirenone
- Adapalene Gel 0.3%
- Adriamycin
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Semapimod
- Neihulizumab
- Esomeprazole 40mg before
- Redifferentiation with retinoid acid
- Palliative care group first-line scheme
- High dose pantoprazole infusion
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Chemotherapeutic Agent
- EFV +TVA
- Cereport
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Glimepiride
- Vehicle
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Austria
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Finland
- Contract Research Organizations in Gabon
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mexico
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Suriname
- Contract Research Organizations in Thailand
- CRO list by country